For years, conversations about artificial intelligence (AI) in life sciences have alternated between hype and hesitation.
When John Carey joined SAS Institute four years ago, his mandate was to rethink what partnering looked like for a company with a long advisory and delivery history but limited co-sell and no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results